Debt-to-equity of RAPT Therapeutics, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
RAPT Therapeutics, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • RAPT Therapeutics, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 13%, a 24% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

RAPT Therapeutics, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 13% -4.1% -24% 30 Sep 2025
Q2 2025 14% -3.2% -19% 30 Jun 2025
Q1 2025 16% +0.74% +4.8% 31 Mar 2025
Q4 2024 20% +6.4% +47% 31 Dec 2024
Q3 2024 17% +5.5% +47% 30 Sep 2024
Q2 2024 17% +6.6% +63% 30 Jun 2024
Q1 2024 15% +4.9% +47% 31 Mar 2024
Q4 2023 14% +3.8% +37% 31 Dec 2023
Q3 2023 12% +1.9% +20% 30 Sep 2023
Q2 2023 11% +1.7% +19% 30 Jun 2023
Q1 2023 10% +2.5% +32% 31 Mar 2023
Q4 2022 10% +2.1% +26% 31 Dec 2022
Q3 2022 9.7% +0.2% +2.1% 30 Sep 2022
Q2 2022 8.9% 30 Jun 2022
Q1 2022 7.9% 31 Mar 2022
Q4 2021 8% 31 Dec 2021
Q3 2021 9.4% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.